Ellagic acid has demonstrated DNA-protecting properties, including the ability to bind to toxins and neutralize them. Studies have also shown that ellagic acid may protect against chromosome damage and reduce the effects of chemically induced hepatic structural degeneration.
Medical findings in Europe show that Ellagic acid may reduce the incidence of birth defects, promote wound healing, reduce and reverse chemically induced liver fibrosis and may help in the fight against heart disease. It also has anti- bacterial and antiviral properties.
Research in US indicates that in the laboratory Ellagic acid slows the growth of abnormal colon cells in humans. It promotes apoptotic growth (natural death) of cancer cells.
Ellagic acid may also be effective for the treatment of ulcer and gastrointestinal disorder such as constipation, heartburn, non-ulcer dyspepsia, and esophagitis.
Hassoun EA, Walter AC, Alsharif NZ, and Stohs SJ. Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid. Toxicology. 1997 Dec 19;124(1):27-37
Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW. p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett. 1999 Mar 1; 136(2):215-21.
Thresiamma KC, Kuttan R. Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol. 1996 Oct;40(4):363-6.
Antipenko AY, Spielman AI, Kirchberger MA. Interactions of 6-gingerol and ellagic acid with the cardiac sarcoplasmic reticulum Ca2+-ATPase. J Pharmacol Exp Ther. 1999 Jul;290(1):227-34.
Narayanan BA, Re GG. IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res. 2001 Jan-Feb;21(1A):359-64.